MedPath

Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding

Phase 3
Terminated
Conditions
Liver Cirrhosis
Esophageal Varices
Registration Number
NCT00337740
Lead Sponsor
University of Padova
Brief Summary

Whether beta-blockers or banding is the best therapy for primary prophylaxis of variceal bleeding is subject to debate. A randomized comparison between the two treatments was performed in candidates for liver transplantation. Patients with Child B and C cirrhosis with high risk varices and no previous variceal bleeding are randomized to propranolol or variceal bleeding. Primary end point is variceal bleeding

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • liver cirrhosis
  • child pugh>=B7
  • studied for transplantation
  • age between 18 an 65 ys
  • no previous bleeding from varices
  • signed informed consent
Exclusion Criteria
  • esophageal varices less than F2 blue
  • gastric varices
  • previous variceal surgical or radiological or endoscopical treatment
  • hepatocarcinoma
  • portal vein thrombosis
  • severe heart, respiratory or renal failure
  • contraindications to betablockers
  • treatment with nitrates, calcium antagonist or anti-arhythmic drugs that can not be suspended
  • Pregnancy
  • neoplasias
  • non cooperation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
variceal bleeding
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinica Chirurgica 1^, Policlinico Universitario, Via Giustiniani 2

🇮🇹

Padova, Italy

© Copyright 2025. All Rights Reserved by MedPath